These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Suga T, Shiio T, Maeda YY, Chihara G. Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173 [Abstract] [Full Text] [Related]
5. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors. Gatanaga T, Takahashi K, Yamazaki M, Mizuno D, Abe S. Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560 [Abstract] [Full Text] [Related]
6. [Suppressive effect of lentinan on pulmonary metastases in murine tumors]. Shiio T, Kitamura K, Ohishi K, Yugari Y. Gan No Rinsho; 1987 Oct; 33(12):1427-30. PubMed ID: 3682194 [Abstract] [Full Text] [Related]
7. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats]. Kosaka A, Imaizumi A, Hatori Y, Mori F, Wani T, Yamashita A. Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243 [Abstract] [Full Text] [Related]
8. Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin-2 and cyclophosphamide. Silagi S, Schaefer AE. J Biol Response Mod; 1986 Oct; 5(5):411-22. PubMed ID: 3490544 [Abstract] [Full Text] [Related]
9. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 3). Combined effect on metastatic tumors]. Shiio T, Ohishi K, Niitsu I, Hayashibara H, Tsuchiya Y, Yoshihama T, Moriyuki H. Gan To Kagaku Ryoho; 1988 Mar; 15(3):481-5. PubMed ID: 3348634 [Abstract] [Full Text] [Related]
10. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors. Sirotnak FM, Otter GM, Schmid FA. Cancer Res; 1993 Feb 01; 53(3):587-91. PubMed ID: 8425192 [Abstract] [Full Text] [Related]
11. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma. Sava G, Giraldi T, Lassiani L, Nisi C. Cancer Res; 1984 Jan 01; 44(1):64-8. PubMed ID: 6690062 [Abstract] [Full Text] [Related]
12. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice. Budzyński W. Arch Immunol Ther Exp (Warsz); 1982 Jan 01; 30(5-6):373-7. PubMed ID: 7184488 [Abstract] [Full Text] [Related]
13. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Saji H, Song W, Furumoto K, Kato H, Engleman EG. Clin Cancer Res; 2006 Apr 15; 12(8):2568-74. PubMed ID: 16638867 [Abstract] [Full Text] [Related]
14. Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs. Rose WC. Cancer Treat Rep; 1981 Apr 15; 65(3-4):299-312. PubMed ID: 7237452 [Abstract] [Full Text] [Related]
20. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor]. Moriya N, Miwa H, Taketsuka S, Orita K. Gan To Kagaku Ryoho; 1983 Jul 15; 10(7):1646-52. PubMed ID: 6870308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]